Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Operating Income: 2011-2025

Historic Operating Income for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to -$7.8 million.

  • Aytu Biopharma's Operating Income fell 61.72% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.4 million, marking a year-over-year decrease of 274.71%. This contributed to the annual value of -$7.8 million for FY2025, which is 259.20% down from last year.
  • As of FY2025, Aytu Biopharma's Operating Income stood at -$7.8 million, which was down 259.20% from -$2.2 million recorded in FY2024.
  • Aytu Biopharma's 5-year Operating Income high stood at -$2.2 million for FY2024, and its period low was -$109.9 million during FY2022.
  • Over the past 3 years, Aytu Biopharma's median Operating Income value was -$7.8 million (recorded in 2025), while the average stood at -$9.0 million.
  • In the last 5 years, Aytu Biopharma's Operating Income skyrocketed by 87.23% in 2024 and then crashed by 259.20% in 2025.
  • Aytu Biopharma's Operating Income (Yearly) stood at -$58.9 million in 2021, then plummeted by 86.69% to -$109.9 million in 2022, then surged by 84.47% to -$17.1 million in 2023, then skyrocketed by 87.23% to -$2.2 million in 2024, then tumbled by 259.20% to -$7.8 million in 2025.